Cell MedX (Cell MedX) Days Payable : 0.00 (As of Feb. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cell MedX Days Payable?

Cell MedX's average Accounts Payable for the three months ended in Feb. 2024 was $0.46 Mil. Cell MedX's Cost of Goods Sold for the three months ended in Feb. 2024 was $0.00 Mil.

The historical rank and industry rank for Cell MedX's Days Payable or its related term are showing as below:

CMXC' s Days Payable Range Over the Past 10 Years
Min: 1656.02 Med: 37960 Max: 154030
Current: 154030

During the past 12 years, Cell MedX's highest Days Payable was 154030.00. The lowest was 1656.02. And the median was 37960.00.

CMXC's Days Payable is ranked better than
99.62% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 72.67 vs CMXC: 154030.00

Cell MedX's Days Payable stayed the same from Feb. 2023 (0.00) to Feb. 2024 (0.00). stayed the same

Cell MedX Days Payable Historical Data

The historical data trend for Cell MedX's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell MedX Days Payable Chart

Cell MedX Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Days Payable

Get a 7-Day Free Trial

29,984.75

81,577.50

79,752.50

77,562.50

Cell MedX Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Payable	Get a 7-Day Free Trial															-	37,184.38	-	-	-

Competitive Comparison of Cell MedX's Days Payable

For the Medical Devices subindustry, Cell MedX's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cell MedX's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cell MedX's Days Payable distribution charts can be found below:

* The bar in red indicates where Cell MedX's Days Payable falls into.

Cell MedX Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cell MedX's Days Payable for the fiscal year that ended in May. 2023 is calculated as

	Days Payable (A: May. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: May. 2022 )	+	Accounts Payable (A: May. 2023 ))	/	count )	/	Cost of Goods Sold (A: May. 2023 )	*	Days in Period
=	( (0.442	+	0.408)	/	2 )	/	0.002	*	365
=	0.425					/	0.002	*	365
=	77,562.50

Cell MedX's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (0.648	+	0.277)	/	2 )	/	0	*	365 / 4
=	0.4625					/	0	*	365 / 4
=	N/A

Cell MedX Days Payable Related Terms

Thank you for viewing the detailed overview of Cell MedX's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cell MedX (Cell MedX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cell MedX Corp (OTCPK:CMXC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

123 W. Nye Lane, Suite 446, Carson City, NV, USA, 89706

Website

https://www.cellmedx.com

Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.

Executives

Richard Jeffs	10 percent owner	FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz	director, officer: Chief Executive Officer	SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves	10 percent owner	904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty	director, officer: CEO, CFO, Treas., Sec	4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta	director, officer: COO	#810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams	director	7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen	director, officer: CEO	635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson	officer: Chief Medical Officer	9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina	officer: CFO, Treasurer and Secretary	789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett	10 percent owner	121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer	director, officer: Chief Technology Officer	C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103

Cell MedX (Cell MedX) Headlines

From GuruFocus

Cell MedX Insider Buys 22,500 Shares

By Kyle Ferguson Kyle Ferguson • 11-11-2016